Get started
Author

Jagdeep S. Singh

Observed names: J S S Singh, J S Singh, J Singh, J. Singh, J.S Singh, J.S.S Singh, JAGDEEP S. SINGH, JAGDEEP S.S. SINGH, Jagdeep S S Singh, Jagdeep S Singh, Jagdeep S. S. Singh, Jagdeep S.S. Singh, Jagdeep Singh, Jagdeep Singh (2314918), Singh, J. S.
Observed institutions: Mount Sinai Beth Israel, Albert Einstein College of Medicine, St. Luke's-Roosevelt Hospital Center, NHS Lothian, University of Dundee, Ninewells Hospital, Edinburgh Royal Infirmary, NHS Fife, Victoria Hospital, Columbia University
ORCID: 0000-0002-7358-9712
Observed ORCID: 0000-0002-7358-9712
OpenAlex ID: A5075118238
Renal and Cardiovascular Effects of SGLT2 Inhibition in Combination With Loop Diuretics in Patients With Type 2 Diabetes and Chronic Heart Failure
2020 · Natalie A. Mordi, Ify R. Mordi, et al. · Circulation · 249
PDF
Sodium-glucose co-transporter 2 inhibitor therapy: mechanisms of action in heart failure
2021 · Shruti S Joshi, Trisha Singh, et al. · Heart · 193
PDF
Dapagliflozin Versus Placebo on Left Ventricular Remodeling in Patients With Diabetes and Heart Failure: The REFORM Trial
2020 · Jagdeep S.S. Singh, Ify R. Mordi, et al. · Diabetes Care · 193
PDF
A randomized controlled trial of metformin on left ventricular hypertrophy in patients with coronary artery disease without diabetes: the MET-REMODEL trial
2019 · Mohapradeep Mohan, Shaween Al-Talabany, et al. · European Heart Journal · 185
SGLT2-inhibitors; more than just glycosuria and diuresis
2020 · Amir Fathi, Keeran Vickneson, et al. · Heart Failure Reviews · 122
PDF
Mean HbA1c and Mortality in Diabetic Individuals with Heart Failure: A Population Cohort Study
2015 · Douglas H.J. Elder, Jagdeep S.S. Singh, et al. · European Journal of Heart Failure · 110
PDF
Protocolized Natriuresis-Guided Decongestion Improves Diuretic Response: The Multicenter ENACT-HF Study
2024 · Jeroen Dauw, Kristina Charaya, et al. · Circulation Heart Failure · 107
PDF
Sacubitril/valsartan: beyond natriuretic peptides
2017 · Jagdeep S S Singh, Louise M Burrell, et al. · Heart · 103
Neutrophil-to-Lymphocyte Ratio and Outcomes in Patients with New-Onset or Worsening Heart Failure with Reduced and Preserved Ejection Fraction
2021 · Fraser M. Curran, U Bhalraam, et al. · ESC Heart Failure · 94
PDF
Changes in health-related quality of life and factors predicting long-term outcomes in older adults admitted to intensive care units*
2011 · Hassan Khouli, Alfred Astua, et al. · Critical Care Medicine · 80
Research into the effect Of SGLT2 inhibition on left ventricular remodelling in patients with heart failure and diabetes mellitus (REFORM) trial rationale and design
2016 · Jagdeep S. S. Singh, Amir Fathi, et al. · Cardiovascular Diabetology · 64
PDF
Renal and Cardiovascular Effects of sodium–glucose cotransporter 2 (SGLT2) inhibition in combination with loop Diuretics in diabetic patients with Chronic Heart Failure (RECEDE-CHF): protocol for a randomised controlled double-blind cross-over trial
2017 · Natalie A Mordi, Ify R Mordi, et al. · BMJ Open · 50
PDF
Rationale and Design of the Efficacy of a Standardized Diuretic Protocol in Acute Heart Failure Study
2021 · Jeroen Dauw, Malgorzata Lelonek, et al. · ESC Heart Failure · 37
PDF
Potential Mechanisms of SGLT2 Inhibitors for the Treatment of Heart Failure With Preserved Ejection Fraction
2021 · Steffen Pabel, Nazha Hamdani, et al. · Frontiers in Physiology · 36
PDF
Management of Noncardiac Comorbidities in Chronic Heart Failure
2015 · Vun Heng Chong, Jagdeep Singh, et al. · Cardiovascular Therapeutics · 35
The renal and cardiovascular effects of SGLT2 inhibition in combination with loop diuretics in patients with type 2 diabetes and chronic heart failure (RECEDE-CHF) trial
2020 · N.A Mordi, I.R Mordi, et al. · European Heart Journal · 25
Angiotensin receptor-neprilysin inhibitors: clinical potential in heart failure and beyond
2015 · Chim Lang, Jagdeep Singh · Vascular Health and Risk Management · 24
PDF
Dapagliflozin reduces epicardial adipose tissue in patients with heart failure and type 2 diabetes
2025 · Mohmmad Alghamdi, Adel Dihoum, et al. · Diabetes Obesity and Metabolism · 15
PDF
The “discordant doppelganger dilemma”: SGLT2i mimics therapeutic carbohydrate restriction - food choice first over pharma?
2021 · Scott W. Murray, Sean McKelvey, et al. · Journal of Human Hypertension · 12
PDF
6 Metformin regresses left ventricular hypertrophy in normotensive patients with coronary artery disease without type 2 diabetes mellitus – the met-remodel trial
2018 · Mohapradeep Mohan, Shaween Al-Talabany, et al. · Heart · 8
Targeting Investigation and Treatment in Type 2 Myocardial Infarction
2025 · Caelan Taggart, Amy Ferry, et al. · JACC Advances · 7
The Importance of Bifurcation Lesions in Patients Undergoing Percutaneous Coronary Interventions in ST-segment Elevation Myocardial Infarction
2013 · Yumiko Kanei, Navin C. Nakra, et al. · Cardiovascular revascularization medicine · 7
Metformin Regresses Left Ventricular Hypertrophy in Normotensive Patients with Coronary Artery Disease without Type 2 Diabetes Mellitus—The MET-REMODEL Trial
2018 · MOHAPRADEEP MOHAN, SHAWEEN AL-TALABANY, et al. · Diabetes · 6
Effect of metformin on epicardial adipose tissue in patients with coronary artery disease without diabetes: A cardiac MRI substudy of the MET-remodel trial
2021 · Shaween Al-Talabany, Mohapradeep Mohan, et al. · Obesity Medicine · 5
Prevalence of Risk Factors in Patients with Myocardial Infarction
2016 · Amanpreet Kaur, Jagdeep Singh · Indian Journal of Public Health Research & Development · 4
Works count: 49
Citation count: 1,783
H-index: 17
I10-index: 19
Year
Topic
Type